Development of inhibitors of the PAS-B domain of the HIF-2α transcription factor

Jamie L Rogers1, Liela Bayeh, Thomas H Scheuermann

  • 1Department of Biochemistry, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States.

Insights

Researchers identified key structural features for small molecules that inhibit Hypoxia-inducible factors (HIFs) by blocking HIF-2α-ARNT interaction. This work lays the groundwork for novel cancer therapeutics targeting this pathway.

Area of Science:

  • Molecular biology
  • Structural biology
  • Drug discovery

Background:

  • Hypoxia-inducible factors (HIFs) are critical transcription factors involved in cellular responses to low oxygen.
  • HIFs play a significant role in various pathophysiological conditions, notably in cancer development and progression.
  • HIF-2α-ARNT heterodimerization is a key interaction in the HIF pathway, making it a target for therapeutic intervention.

Purpose of the Study:

  • To conduct the first detailed structure-activity relationship (SAR) study of small molecules inhibiting HIF-2α-ARNT heterodimerization.
  • To elucidate the structural requirements for small molecule inhibitors that bind to an internal cavity of the HIF-2α PAS-B domain.
  • To provide a foundation for developing novel therapeutic agents targeting the HIF pathway.

Main Methods:

  • Utilized a series of biophysical characterizations to study inhibitor-protein interactions.
  • Employed Nuclear Magnetic Resonance (NMR) spectroscopy to assess binding and structural effects.
  • Applied X-ray crystallography to determine high-resolution structures of inhibitor-protein complexes.

Main Results:

  • Established the precise structural requirements for small molecules designed to inhibit HIF-2α-ARNT heterodimerization.
  • Identified an internal cavity within the HIF-2α PAS-B domain as a binding site for these inhibitors.
  • Characterized the molecular interactions governing the inhibition of HIF-2α-ARNT complex formation.

Conclusions:

  • The study provides critical insights into the SAR of small molecule inhibitors targeting HIF-2α-ARNT interaction.
  • The findings offer a structural basis for the rational design of novel therapeutic agents.
  • This research may lead to new treatment strategies for diseases where HIF signaling is dysregulated, particularly cancer.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Transcription Attenuation in Prokaryotes02:42

Transcription Attenuation in Prokaryotes

Transcriptional attenuation occurs when RNA transcription is prematurely terminated due to the formation of a terminator mRNA hairpin structure.  Bacteria use these hairpins to regulate the transcription process and control the synthesis of several amino acids including histidine, lysine, threonine, and phenylalanine. Transcription attenuation takes place in the non-coding regions of mRNA.
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...